Does H. pylori therapy augments the effect of iron therapy among children with iron deficiency anemia?

Authors

  • Arif Husain Department of Pediatrics, Eras Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India
  • Shrish Bhatnagar Department of Pediatrics, Eras Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20201139

Keywords:

H. pylori therapy, Iron deficiency anemia, Rapid urease test, S. Iron

Abstract

Background: To assess beneficial effects of H. pylori therapy on children with pre-existing Iron Deficiency Anemia (IDA).

Methods: A total of 218 consecutive patients with iron deficiency anemia (Hb 6-11 gm/dl) were invited to participate in the study. Patients underwent endoscopic biopsy and rapid urease test for H. pylori detection. A total of three groups were formed- Group I (n=13) - positive for H. pylori, underwent treatment for H. pylori therapy and IDA, Group II (n=16) - positive for H. pylori, underwent treatment for IDA only, Group III (n=101) - negative for H. pylori, underwent treatment for IDA only. All the patients were followed up after every 4 weeks till week 12. Change in haematological parameters and anaemic and iron status was assessed. Chi-square paired ‘t’-test and ANOVA were used using SPSS 21.0.

Results: All the 3 groups showed a significant increase in S. Hb, Ferritin and iron levels and a decrease in S. TIBC levels. At 12 weeks, mean S. ferritin and S. iron levels were significantly higher in Groups I and III as compared to Group II while Mean S. TIBC levels were significantly higher in Group II as compared to that in Groups I and II. A total of 73.3% of Group III, 53.8% of Group I and 56.3% of Group II patients had hemoglobin levels >11 g/dl, but difference was not significant (p=0.175).

Conclusions: The findings of study showed that H. pylori therapy augments the effect of iron therapy among H. pylori positive children with iron deficiency anemia.

References

WHO/UNICEF/UNU (2001) Iron deficiency anaemia assessment, prevention, and control. Geneva: World Health Organization. Available at: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf. Accessed 15 March 2016.

Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007 Aug 11;370(9586):511-20.

United Nations Administrative Committee on Coordination ScoNAS. Fourth Report on World Nutrition situation. Geneva, Switzerland: ACC/SCN in collaboration with International Food Policy Research Institute, 2000.

Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ. 1997;314:1430-1.

Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Ind J Med Res. 2012 Oct;136(4):549.

Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nature Rev Gastroenterol Hepatol. 2011 Feb;8(2):79.

Cardenas VM, Ortiz M, Graham DY, Gessner BD, Baggett HC, Dunaway E, et al. Helicobacter pylori Eradication and Its Effect on Iron Stores: A Reappraisal [with Reply to Cardenas et al.]. J Infec Dis. 2006 Sep 1;194(5):714-6.

Devarbhavi H, Nanivadekar S, Sawant P, Saraswathy K. Sensitivity of Helicobacter pylori isolates from Indian patients to different antibacterial agents. Ind J Gastroenterol. 1998;17(Suppl 1):S53.

Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997 Dec 1;113(6):1983-91.

Ahmed KS, Khan AA, Ahmed I, Tiwari SK, Habeeb A, Ahi JD, et al. Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J. 2007 Jun;48(6):543.

Yokota SI, Konno M, Mino E, Sato K, Takahashi M, Fujii N. Enhanced Fe ion-uptake activity in Helicobacter pylori strains isolated from patients with iron-deficiency anemia. Clin Infec Dis. 2008 Feb 15;46(4):e31-3.

Yip R, Limburg PJ, Ahlquist DA, Carpenter HA, O'Neill A, Kruse D, et al. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency: role of Helicobacter pylori gastritis. Jama. 1997 Apr 9;277(14):1135-9.

Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003 Apr 1;52(4):496-501.

Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle?. Pediatrics. 2007 Mar 1;119(3):e754-9.

Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991;32:1415-8.

Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology. 2007 Jul 1;133(1):288-308.

Gessner BD, Bruce MG, Parkinson AJ, Gold BD, Muth PT, Dunaway E, et al. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection. Clin Infec Dis. 2005 Nov 1;41(9):1261-8.

Dore SP, Krupadas S, Borgonha S, Kurpad AV. The 13C urea breath test to assess Helicobacter pylori infection in school children. National Med J Ind. 1997;10(2):57-60.

Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, et al. Seroepidemiology of Helicobacter pylori infection in India. Diges Dis Sci. 1991 Aug 1;36(8):1084-8.

Gill HH, Majmudar P, Shankaran K, Desai HG. Age related prevalence of Helicobacter pylori antibodies in Indian subjects. Ind J Gastroenterol. 1994 Jul 1;13:92.

Jais M, Barua S. Seroprevalence of anti-Helicobacter pylori IgG/IgA in asymptomatic population from Delhi. J Commun Dis. 2004 Jun;36(2):132-5.

Ahmed KS, Khan AA, Ahmed I, Tiwari SK, Habeeb MA, Ali SM, et al. Prevalence study to elucidate the transmission pathways of Helicobacter pylori at oral and gastroduodenal sites of a South Indian population. Singapore Med J. 2006;47:291-6.

Katelaris PH, Tippett GH, Norbu P, Lowe DG, Brennan R, Farthing MJ. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut. 1992 Nov 1;33(11):1462-6.

Misra V, Misra SP, Dwivedi M, Singh PA. 'Point Prevalence of Peptic Ulcer and Gastric Histology in Healthy Indians with Helicobacter pylori Infection. Am J Gastroenterol. 1997 Sep 1;92(9):1487-9.

Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron deficiency anemia in pre-adolescent children and adolescents. Helicobacter. 1999;131:668-72.

Valiyaveettil AN, Hamide A, Bobby Z, Krishnan R. Effect of anti-Helicobacter pylori therapy on outcome of iron-deficiency anemia: a randomized, controlled study. Ind J Gastroenterol. 2005;24:155-7.

Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006 Jan 15;163(2):127-34.

Chen LH, Luo HS. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. World J Gastroenterol: WJG. 2007 Oct 28;13(40):5380.

DiGirolamo AM, Perry GS, Gold BD, Parkinson A, Provost EM, Parvanta I, et al. Helicobacter pylori, anemia, and iron deficiency: relationships explored among Alaska native children. Pediatr Infec Dis J. 2007 Oct 1;26(10):927-34.

Sarker SA, Mahmud H, Davidsson L, Alam NH, Ahmed T, Alam N, et al. Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. Gastroenterology. 2008 Nov 1;135(5):1534-42.

Haghi-Ashtiani MT, Monajemzadeh M, Motamed F, Mahjoub F, Sharifan M, Shahsiah R, et al. Anemia in children with and without Helicobacter pylori infection. Arch Med Res. 2008;39(5):536-40.

Downloads

Published

2020-03-21

Issue

Section

Original Research Articles